Literature DB >> 15976991

Manifestations of hereditary hemorrhagic telangiectasia in children and adolescents.

Benedikt J Folz1, Barbara Zoll, Heiko Alfke, André Toussaint, Rolf F Maier, Jochen A Werner.   

Abstract

The medical literature provides little information on manifestations of hereditary hemorrhagic telangiectasia (HHT) in children. The presented investigation was initiated to analyze early presenting symptoms in HHT, which should help to make the diagnosis at a young age and thus prevent potential complications from occult visceral arteriovenous malformations (AVM), which have commonly been described in HHT. A series of 15 children and adolescents with a suspicious diagnosis of HHT were examined clinically for typical signs and symptoms of the disorder. If the diagnosis of HHT seemed to be likely, recommendations for non-invasive screening procedures were given. Screening was directed at the detection of occult visceral AVMs. Main outcome measures were the definition of principal signs of HHT in children and adolescents. Family history was positive for HHT in 13 persons. The principal sign of recurrent epistaxis was present in 10/15 individuals and the earliest age of onset with regard to epistaxis was 4 years. Cutaneous vascular lesions were present in 5/15 patients. Screening for AVMs was performed in six individuals and revealed vascular lesions of the brain in two patients and vascular lesions of the lung in two patients. Gastrointestinal hemorrhages were present in one infant. Based on these findings, diagnosis of HHT seemed likely in ten individuals and unlikely in five individuals. Signs and symptoms of HHT in children and adolescents may be discrete, but are detectable at an earlier age than previously thought. Clinical examinations in children from HHT families may help identify candidates who will benefit from molecular genetic testing or screening imaging studies.

Entities:  

Mesh:

Year:  2005        PMID: 15976991     DOI: 10.1007/s00405-005-0956-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  53 in total

1.  Spinal arterial malformation in a child with hereditary hemorrhagic telangiectasia. Case report.

Authors:  G S Merry; D B Appleton
Journal:  J Neurosurg       Date:  1976-05       Impact factor: 5.115

2.  [Universal organ involvement in Rendu-Osler-Weber disease: interdisciplinary diagnosis and interventional therapy].

Authors:  J Kirchner; A Zipf; C F Dietrich; A Hohmann; R Heyd; J Berkefeld
Journal:  Z Gastroenterol       Date:  1996-11       Impact factor: 2.000

3.  Radiological case of the month. Pulmonary arteriovenous fistula associated with Rendu-Osler-Weber syndrome.

Authors:  S M Audenaert; B P Wood
Journal:  Am J Dis Child       Date:  1990-05

4.  Morphology and distribution of nasal telangiectasia in HHT-patients with epistaxis.

Authors:  Benedikt J Folz; Ana Cerra Wollstein; Burkard M Lippert; Jochen A Werner
Journal:  Am J Rhinol       Date:  2005 Jan-Feb

Review 5.  Pulmonary arteriovenous malformation in the newborn: a familial case.

Authors:  S W Allen; J M Whitfield; D R Clarke; E Sujansky; J W Wiggins
Journal:  Pediatr Cardiol       Date:  1993-01       Impact factor: 1.655

6.  Osler-Weber-Rendu syndrome--pathological manifestations and autopsy considerations.

Authors:  R W Byard; J Schliebs; B A Koszyca
Journal:  J Forensic Sci       Date:  2001-05       Impact factor: 1.832

7.  Chronic painless hematuria and urethral bleeding as the presenting manifestations of Osler-Weber-Rendu disease.

Authors:  C S Kitchens; R Lottenberg
Journal:  J Urol       Date:  1976-11       Impact factor: 7.450

8.  [Transcatheter embolization of pulmonary arteriovenous fistulas].

Authors:  M Wingen; R W Günther
Journal:  Rofo       Date:  2001-07

9.  Pial arteriovenous fistula in children as presenting manifestation of Rendu-Osler-Weber disease.

Authors:  R García-Mónaco; W Taylor; G Rodesch; H Alvarez; P Burrows; P Coubes; P Lasjaunias
Journal:  Neuroradiology       Date:  1995-01       Impact factor: 2.804

Review 10.  [Recurrent epistaxis in children as an indicator of hemostatic disorders].

Authors:  F J García Callejo; M M Velert Vila; J Marco Algarra
Journal:  An Esp Pediatr       Date:  1998-11
View more
  5 in total

1.  First experiences with an individual nasal olive in patients with hereditary haemorrhagic telangiectasia (HHT).

Authors:  Basel Al Kadah; George Papaspyrou; Mathias Schneider; Bernhard Schick
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-05-23       Impact factor: 2.503

Review 2.  Diagnosis and management of heart failure in the fetus.

Authors:  B Davey; A Szwast; J Rychik
Journal:  Minerva Pediatr       Date:  2012-10       Impact factor: 1.312

3.  A retrospective analysis of low dose, intranasal injected bevacizumab (Avastin) in hereditary haemorrhagic telangiectasia.

Authors:  C Rohrmeier; H G Sachs; T S Kuehnel
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-07-31       Impact factor: 2.503

4.  A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: a questionnaire-based retrospective study.

Authors:  Paola Pierucci; Gennaro M Lenato; Patrizia Suppressa; Patrizia Lastella; Vincenzo Triggiani; Raffaella Valerio; Mario Comelli; Daniela Salvante; Alessandro Stella; Nicoletta Resta; Giancarlo Logroscino; Francesco Resta; Carlo Sabbà
Journal:  Orphanet J Rare Dis       Date:  2012-06-07       Impact factor: 4.123

5.  Hereditary Hemorrhagic Telangiectasia: A Rare Cause of Anemia.

Authors:  Waseem Jan; Asim Tameez Ud Din; Farooq Mohyud Din Chaudhary; Ahsan Tameez-Ud-Din; Faisal Nawaz
Journal:  Cureus       Date:  2019-08-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.